High-dose intravenous immunoglobulin therapy and neonatal jaundice due to red blood cell alloimmunization;Immunoglobulines polyvalentes intraveineuses et ictère néonatal par allo-immunisation érythrocytaire

Archives de Pediatrie

Volumn 16, Issue 9, 2009, Pages 1289-1294

  Monpoux, F ^a   Dageville, C ^a   Maillotte, A M ^a   De Smet, S ^a   Casagrande, F ^a   Boutte P ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN D ANTIBODY; RHESUS ANTIGEN;

ABSENCE OF SIDE EFFECTS; ALLOIMMUNIZATION; BLOOD GROUP ABO INCOMPATIBILITY; DRUG MEGADOSE; ERYTHROCYTE; EXCHANGE BLOOD TRANSFUSION; GESTATIONAL AGE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; KERNICTERUS; LENGTH OF STAY; NEWBORN; NEWBORN HEMOLYTIC DISEASE; NEWBORN JAUNDICE; PHOTOTHERAPY; SHORT SURVEY;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ERYTHROBLASTOSIS, FETAL; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT, NEWBORN; JAUNDICE, NEONATAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RH ISOIMMUNIZATION; TREATMENT OUTCOME;

EID: 68349128632     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2009.05.015     Document Type: Short Survey

References (24)

1. Maisels M.J., and MacDonagh A.F. Phototherapy for neonatal jaundice. N Engl J Med 358 (2008) 920-928
2. American Academy of Pediatrics Subcommittee on hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114 (2004) 297-316
3. Guitton C., Garçon L., Cynober T., et al. Sphérocytose héréditaire : recommandations pour le diagnostic et la prise en charge chez l'enfant. Arch Pediatr 15 (2008) 1464-1473
4. Urbaniak S.J., and Greiss M.A. RhD haemolytic disease of the fetus and the newborn. Blood Rev 14 (2000) 44-61
5. Kaplan M., Merlob P., and Regev R. Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus. J Perinatol 28 (2008) 389-397
6. Gottstein R., and Cooke R.W. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 88 (2003) F6-F10
7. Steiner L.A., Bizzarro M.J., Ehrenkrenz R.A., et al. A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality. Pediatrics 120 (2007) 27-32
8. Huizing K., Røislien J., and Hansen T. Intravenous immune globulin reduces the need for exchange transfusions in Rhesus and AB0 incompatibility. Acta Paediatr 97 (2008) 1362-1365
9. Girish G., Chawla D., Agarwal R., et al. Efficacy of two dose regims of intravenous immunoglobulin in Rh hemolytic disease of newborn-a randomized controlled trial. Indian Pediatr 45 (2008) 653-659
10. Walsh S.A., Yao N., El-Khuffash A., et al. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn. Ir Med J 101 (2008) 46-48
11. Oh E.J., Jekarl D.W., Jang H.S., et al. Severe hemolytic disease of the newborn due to anti-Di b treated with phototherapy and intravenous immunoglobulin. Ann Clin Lab Sci 38 (2008) 80-82
12. Nasseri F., Mamouri G.A., and Babaei H. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn. Saudi Med J 27 (2006) 1827-1830
13. Miqdad A.M., Abdelbasit O.B., Shaheed M.M., et al. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. J Matern Fetal Neonatal Med 16 (2004) 163-166
14. Voto L.S., Sexer H., Ferreiro G., et al. Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease. J Perinat Med 23 (1995) 443-451
15. Sato K., Hara T., Kondo T., et al. High-dose intravenous gammaglobulin therapy for neonatal immune haemolytic jaundice due to blood group incompatibility. Acta Paediatr Scand 80 (1991) 163-166
16. Rübo J., Albrecht K., Lasch P., et al. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr 121 (1992) 93-97
17. Dagoglu T., Ovali F., Samaci N., et al. High-dose intravenous immunoglobulin therapy for rhesus haemolytic diseases. J Int Med Res 23 (1995) 264-271
18. Alpay F., Sarici S.U., Okutan V., et al. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. Acta Paediatr 88 (1999) 216-219
19. Hammerman C., Vreman H.J., and Stevenson D.K. Intravenous immune globulin in neonatal immune hemolytic disease: does it reduce hemolysis?. Acta Paediatr 85 (1996) 1351-1353
20. Le Meignen M., Mossler P., Mates M., et al. Purpura thrombocytopénique auto-immun : à propos d'une cohorte prospective de 147 enfants pris en charge dans le réseau pédiatrique des regions PACA et Corse (RHéma). Arch Pediatr 15 (2008) 1398-1406
21. Quartier P., Debré M., De Blic J., et al. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr 134 (1999) 589-596
22. Pinna G.S., Kafetzis D.A., Tselkas O.I., et al. Kawasaki disease: an overview. Curr Opin Infect Dis 21 (2008) 263-270
23. Hooper J.A. Intravenous immunoglobulins: evolution of commercial IVIG preparations. Immunol Allergy Clin North Am 28 (2008) 765-778
24. Recommandations du CEDIT: http://www.afssaps.fr/Dossiers-thematiques/Tarification-a-l-activite-T2A-medicaments/Immunoglobulines/. Également consultables : http://cedit.aphp.fr/ (site consulté le 29 juin 2009).